Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM) Competitive Revisions (U19)
The summary for the Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM) Competitive Revisions (U19) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM) Competitive Revisions (U19): Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to notify NIAID Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM) U19 grantees of the opportunity to expand the scope of their current IPCP-HTM award. The IPCP-HTM program supports multi-project, multi-disciplinary preclinical and exploratory clinical studies to advance safe, effective and acceptable novel topical microbicides and microbicide combination strategies for the prevention of HIV. Competitive revisions may be used to address gaps or opportunities in funded IPCP-HTM programs. Applicants propose to expand the scope of a current IPCP-HTM award Mechanism of Support. This Competitive Revision FOA will utilize the multi-project Cooperative Agreement (U19) award mechanism. A FOA of identical scientific scope, RFA-AI-10-006, for new IPCP-HTM awards is being published closely with this FOA. Funds Available and Anticipated Number of Awards. NIAID and NIMH anticipate making awards for a total of $6 million in FY 2011 for the combination of the Competitive Revision IPCP-HTM applications under this FOA and applications to RFA-AI-10-006, IPCP-HTM FOA. At least 1 award is anticipated.
Federal Grant Title: | Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM) Competitive Revisions (U19) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AI-10-007 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.242 |
CFDA Descriptions: | Mental Health Research Grants |
Current Application Deadline: | Nov 17, 2010 |
Original Application Deadline: | Nov 17, 2010 |
Posted Date: | Aug 02, 2010 |
Creation Date: | Aug 02, 2010 |
Archive Date: | Dec 18, 2010 |
Total Program Funding: | $6,000,000 |
Maximum Federal Grant Award: | $1,400,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Eligible institutions are current NIAID IPCP-HTM awardees.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH...
- • Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional...
- • Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
- • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
- More Grants from the National Institutes of Health
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...